POY_1170x120_8-12-19

Ben Ward

Lovell Drugs signs supply deal for medicinal cannabis

Lovell Drugs signs supply deal for medicinal cannabis

TORONTO — Canada’s Lovell Drugs has entered into a definitive agreement with Maricann Group Inc. to be the exclusive supplier of medicinal cannabis to its pharmacies. Maricann said that Lovell has begun dispensing medical marijuana to its patients, registering and filling its first medicinal cannabis prescription registered and fulfilled on Dec. 1. The drug chain

Lovell Drugs enlists Maricann to supply medicinal cannabis

Lovell Drugs enlists Maricann to supply medicinal cannabis

TORONTO — Ontario pharmacy chain Lovell Drugs has signed a letter of intent with Maricann Group Inc. to be its exclusive supplier of medicinal cannabis. Under the planned four-year pact, the companies would work together to develop processes to facilitate the distribution and sale of Maricann’s medicinal cannabis to patients through Lovell Drugs retail pharmacies,